| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7,500 | $12,075 | $1.61 | 03 Sep 2025 | By Trust |
| Vascular Biogenics Ltd. | Director | Ordinary Shares | 60,000 | 01 Jan 2023 | Direct | ||
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15,000 | 03 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Director | 04 Sep 2025, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 29 Sep 2023 | 1 | $0 | 4 | Director | 03 Oct 2023, 17:00 |
| /report/000149315223000178-ben-zvi-shmuel-2023-01-01 | Vascular Biogenics Ltd. | 01 Jan 2023 | 0 | $0 | 3 | Director | 03 Jan 2023, 20:03 |
| PLX | Protalix BioTherapeutics, Inc. | 07 Sep 2022 | 1 | $0 | 4 | Director | 09 Sep 2022, 17:04 |
| PLX | Protalix BioTherapeutics, Inc. | 30 Jun 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 16:32 |
| PLX | Protalix BioTherapeutics, Inc. | 30 Jun 2022 | 0 | $0 | 3 | Director | 05 Jul 2022, 16:30 |